Collegium Pharmaceutical Current Deferred Revenue (Quarterly) Analysis

Collegium Pharmaceutical, Inc. (COLL)

47.11 -2.37 (-4.79%) USD | NASDAQ | Dec 30, 16:00

47.26 +0.15 (+0.32%) After-Hours: 20:00

View Current Deferred Revenue (Quarterly) for COLL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Catalyst Pharmaceuticals, Inc.	--
Intuitive Surgical, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Altimmune, Inc.	--
Vertex Pharmaceuticals, Inc.	--